Table 2. Cell cycle and sub-G1 distributions shown in Fig. 1D.
Cisplatin (μM) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 10 | 30 | |||||||||||
Sub-G1 | G1 | S | G2/M | Sub-G1 | G1 | S | G2/M | Sub-G1 | G1 | S | G2/M | ||
LoVo | 0.6% | 64.0% | 18.8% | 16.8% | 3.4% | 11.2% | 17.9% | 67.0% | 49.3% | 33.2% | 8.5% | 9.2% | |
cisplatinr/LoVo | #10 | 0.5% | 67.7% | 15.2% | 16.8% | 3.9% | 15.7% | 21.4% | 59.5% | 6.8% | 39.9% | 26.3% | 27.4% |
#19 | 0.4% | 65.8% | 16.3% | 17.6% | 5.3% | 15.0% | 26.8% | 53.5% | 13.4% | 43.9% | 19.8% | 23.2% | |
#54 | 1.3% | 73.4% | 11.7% | 14.0% | 1.9% | 25.7% | 13.9% | 58.9% | 3.1% | 49.8% | 22.3% | 25.2% |